Market Report, "Israel Pharmaceuticals & Healthcare Report Q3 2012", Published
BMI View: Israel's innovative pharmaceutical industry continues to emerge from its strong generic drugs heritage. While most multinationals do not have a direct discovery or manufacturing presence, we expect an increasing number to look to enter through tie-ups and acquisitions of innovative local start-up companies.
View full press release